Monitoring Specific T-Cell Responses to Melanoma Vaccines: ELISPOT, Tetramers, and Beyond

door Gajewski, Thomas F.
Gepubliceerd in 2000

Molecular profiling of melanoma and the evolution of patient-specific therapy

door Gajewski, Thomas F.
Gepubliceerd in 2011

Cancer immunotherapy

door Gajewski, Thomas F.
Gepubliceerd in 2012

The next hurdle in cancer immunotherapy: Overcoming the non-T cell-inflamed tumor microenvironment

door Gajewski, Thomas F.
Gepubliceerd in Semin Oncol (2015)

An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells

door Zha, Yuanyuan, Gajewski, Thomas F.
Gepubliceerd in 2007

New perspectives on type I IFNs in cancer

door Gajewski, Thomas F., Corrales, Leticia
Gepubliceerd in Cytokine Growth Factor Rev (2015)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion

door Spranger, Stefani, Gajewski, Thomas F.
Gepubliceerd in J Immunother Cancer (2015)

Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy

door Corrales, Leticia, Gajewski, Thomas F.
Gepubliceerd in Cytokine (2015)

Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer

door Corrales, Leticia, Gajewski, Thomas F.
Gepubliceerd in Clin Cancer Res (2015)

Tumor-intrinsic oncogene pathways mediating immune avoidance

door Spranger, Stefani, Gajewski, Thomas F.
Gepubliceerd in Oncoimmunology (2015)

The microbiota: a new variable impacting cancer treatment outcomes

door Fessler, Jessica, Gajewski, Thomas F.
Gepubliceerd in Clin Cancer Res (2017)

Impact of oncogenic pathways on evasion of antitumour immune responses

door Spranger, Stefani, Gajewski, Thomas F.
Gepubliceerd in Nat Rev Cancer (2018)

Back from the dead: TIL apoptosis in cancer immune evasion

door Horton, Brendan L, Gajewski, Thomas F
Gepubliceerd in Br J Cancer (2018)

cDC1 dysregulation in cancer: An opportunity for intervention

door Gajewski, Thomas F., Cron, Kyle R.
Gepubliceerd in J Exp Med (2020)

Targeted therapeutics in melanoma

door Gajewski, Thomas F., Hodi, F. Stephen.
Gepubliceerd in 2012.

Molecular regulation of T-cell anergy

door Zheng, Yan, Zha, Yuanyuan, Gajewski, Thomas F
Gepubliceerd in 2008

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

door Zhang, Long, Gajewski, Thomas F., Kline, Justin
Gepubliceerd in 2009

Costimulatory and coinhibitory receptors in anti-tumor immunity

door Driessens, Gregory, Kline, Justin, Gajewski, Thomas F.
Gepubliceerd in 2009

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling

door Spranger, Stefani, Horton, Brendan, Gajewski, Thomas F
Gepubliceerd in J Immunother Cancer (2015)

MYC — a thorn in the side of cancer immunity

door Spranger, Stefani, Gajewski, Thomas F, Kline, Justin
Gepubliceerd in Cell Res (2016)